These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26178718)

  • 1. Developmental Programming: Does Prenatal Steroid Excess Disrupt the Ovarian VEGF System in Sheep?
    Ortega HH; Veiga-Lopez A; Sreedharan S; del Luján Velázquez MM; Salvetti NR; Padmanabhan V
    Biol Reprod; 2015 Sep; 93(3):58. PubMed ID: 26178718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Programming: Prenatal Testosterone Excess on Ovarian SF1/DAX1/FOXO3.
    Puttabyatappa M; Matiller V; Stassi AF; Salvetti NR; Ortega HH; Padmanabhan V
    Reprod Sci; 2020 Jan; 27(1):342-354. PubMed ID: 32046386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.
    Padmanabhan V; Salvetti NR; Matiller V; Ortega HH
    Endocrinology; 2014 Sep; 155(9):3649-60. PubMed ID: 25061847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep.
    Smith P; Steckler TL; Veiga-Lopez A; Padmanabhan V
    Biol Reprod; 2009 Apr; 80(4):726-36. PubMed ID: 19092114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.
    Ortega HH; Rey F; Velazquez MM; Padmanabhan V
    Biol Reprod; 2010 Jun; 82(6):1065-75. PubMed ID: 20147730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance.
    Ortega HH; Salvetti NR; Padmanabhan V
    Reproduction; 2009 May; 137(5):865-77. PubMed ID: 19261835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep.
    Salvetti NR; Ortega HH; Veiga-Lopez A; Padmanabhan V
    Biol Reprod; 2012 Jul; 87(1):22, 1-10. PubMed ID: 22539681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of follicular development by direct single injection of vascular endothelial growth factor gene fragments into the ovary of miniature gilts.
    Shimizu T; Jiang JY; Iijima K; Miyabayashi K; Ogawa Y; Sasada H; Sato E
    Biol Reprod; 2003 Oct; 69(4):1388-93. PubMed ID: 12826586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor receptor signal transduction blocks follicle progression but does not necessarily disrupt vascular development in perinatal rat ovaries.
    McFee RM; Artac RA; McFee RM; Clopton DT; Smith RA; Rozell TG; Cupp AS
    Biol Reprod; 2009 Nov; 81(5):966-77. PubMed ID: 19605787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone.
    Steckler T; Manikkam M; Inskeep EK; Padmanabhan V
    Endocrinology; 2007 Jul; 148(7):3532-40. PubMed ID: 17446188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental Programming: Gestational Exposure to Excess Testosterone Alters Expression of Ovarian Matrix Metalloproteases and Their Target Proteins.
    Puttabyatappa M; Irwin A; Martin JD; Mesquitta M; Veiga-Lopez A; Padmanabhan V
    Reprod Sci; 2018 Jun; 25(6):882-892. PubMed ID: 28299992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment.
    Steckler T; Wang J; Bartol FF; Roy SK; Padmanabhan V
    Endocrinology; 2005 Jul; 146(7):3185-93. PubMed ID: 15802500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, VEGFR-1 and VEGFR-2 immunoreactivity in the porcine arteries of vascular subovarian plexus (VSP) during the estrous cycle.
    Postek A; Andronowska A; Doboszyńska T; Niewegłowski H; Jankowska K
    Folia Histochem Cytobiol; 2006; 44(1):17-23. PubMed ID: 16584087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental programming: postnatal estradiol amplifies ovarian follicular defects induced by fetal exposure to excess testosterone and dihydrotestosterone in sheep.
    Veiga-Lopez A; Wurst AK; Steckler TL; Ye W; Padmanabhan V
    Reprod Sci; 2014 Apr; 21(4):444-55. PubMed ID: 24077439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of angiogenic growth factors and their receptors in ovarian follicles throughout the estrous cycle in the ewe.
    Chowdhury MW; Scaramuzzi RJ; Wheeler-Jones CP; Khalid M
    Theriogenology; 2010 Apr; 73(7):856-72. PubMed ID: 20042232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental Programming: Sheep Granulosa and Theca Cell-Specific Transcriptional Regulation by Prenatal Testosterone.
    Puttabyatappa M; Guo X; Dou J; Dumesic D; Bakulski KM; Padmanabhan V
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32516392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of vascular endothelial growth factor and its receptors (flt1/fms, flk1/KDR, flt4) and vascular endothelial growth inhibitor in the bovine uterus during the sexual cycle and their correlation with serum sex steroids.
    Sağsöz H; Saruhan BG
    Theriogenology; 2011 Jun; 75(9):1720-34. PubMed ID: 21396695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.
    Gómez R; Ferrero H; Delgado-Rosas F; Gaytan M; Morales C; Zimmermann RC; Simón C; Gaytan F; Pellicer A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2484-92. PubMed ID: 21646367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
    Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
    Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.